New Viral Vectors Plants Revealed for France and Germany
New Viral Vectors Plants Revealed for France and Germany
GALWAY, IRELAND--June 29, 2021--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--With demand for viral vectors greatly outstripping capacity, two European contract development and manufacturing organisations (CDMOs) have announced separate plans to build new cell and gene therapy plants in France and Germany.
Within this article: Details investment, project goals, products and timelines
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- MidOcean Energy Acquires 20% Interest in Peru LNG Project
- Tennessee Sees $21 Billion Worth of Projects Under Construction
- Indiana Home to $28 Billion in Manufacturing Projects
- Rising Demand for Propylene Spurs Investments in Propane Dehydrogenation Un...
- ISM: U.S. Manufacturing Activity Expands for First Time Since 2022
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
